Weight-loss medications: what options exist in Europe
Medicines used for overweight and obesity are selected according to the approved indication, a person’s health and local availability. They include injections as well as other formulations.
Types of medicines used in obesity care
European obesity care includes medicines with different mechanisms. Well-known options include GLP-1 receptor agonists, combined GIP/GLP-1 activity and other anti-obesity medicines. Availability varies by member state.
GLP-1, semaglutide and tirzepatide
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both GIP and GLP-1 receptors. These treatments are not interchangeable and suitability must be assessed individually.
The aim of medical treatment is long-term management of a chronic disease and its health risks, not a quick cosmetic loss of a few kilograms. Clinicians therefore assess more than BMI alone.
What to review before treatment
current medical conditions and medicines
previous weight-management attempts
contraindications and potential adverse effects
a realistic follow-up and monitoring plan
Related topics
Weight-loss injections: what they are and when they are usedThe phrase “weight-loss injections” usually refers to prescription medicines used in obesity care. They are not over-the-counter products and they are not suitable for everyone.→
GLP-1 and weight loss: what the term actually meansGLP-1 is a hormonal signal involved in appetite, food intake and metabolism. Some medicines mimic this pathway, while others combine it with additional hormonal activity.→
Weight loss prescriptionModern obesity medicines such as Wegovy and Mounjaro are prescription treatments in the EU. A clinician reviews your health, current medicines and relevant risks before deciding whether treatment is appropriate.→
Sources and review
Information is based on European regulatory sources. Availability, reimbursement and prescribing rules vary between EU countries.
With your consent, our server measures visits and departures to the partner. BMI, height and weight are not sent to analytics. Declining does not affect the website.
